Article
DOJ To Scrutinize Pharmaceutical Industry Conduct For FCPA Violations
The U.S. Justice Department has put the pharmaceutical industry squarely on notice that its overseas business dealings will be scrutinized through the high-powered lens of a prosecutorial microscope.
Bracewell LLP
